A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia

A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia

Authors

  • Miriana Rocchi U.O. Medicina Interna 1, Ospedale “F. Lotti”, Pontedera (PI)

DOI:

https://doi.org/10.7175/cmi.v4i2S.1071

Keywords:

Chronic myeloid leukemia, Imatinib resistance, Chronic lymphocytic leukemia, Nilotinib

Abstract

Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are the most common leukemias of the elderly. However, the sequential occurrence of CML followed by CLL in the same patient is extremely rare. We present a report of a 70-year-old man who developed CLL six years after the diagnosis of CML in molecular, cytogenetic and morphologic remission. The diagnosis of CLL is confirmed by peripheral lymphocytosis. The first line therapy in CML in chronic phase is still imatinib, but in the present case the patient was intolerant to imatinib, therefore he switched to nilotinib after few months.

Downloads

Published

2015-10-13

Issue

Vol. 4 No. 2S (2010)

Section

Case report

License

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)